Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension

Pulmonary Circulation

Volumn 1, Issue 2, 2011, Pages 239-243

  Thamm, Melanie ^a   Voswinckel, Robert ^a   Tiede, Henning ^a   Lendeckel, Friederike ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a   Ghofrani, Hossein A ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Air travel; High altitude; Hypoxic pulmonary vasoconstriction; Pulmonary hypertension; Safety

Indexed keywords

EID: 84855371495     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.83451     Document Type: Article

References (16)

1. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54 Suppl 1:S55-66.
2. Barst RJ, Gibbs JS, Ghofrani HA, Hoeper MM, McLaughlin VV, Rubin LJ, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009;54 Suppl 1:S78-84.
3. Cummins RO, Chapman PJ, Chamberlain DA, Schubach JA, Litwin PE. In-flight deaths during commercial air travel: How big is the problem? JAMA 1988;259:1983-8.
4. DeJohn CA. The evaluation of in-flight medical care aboard selected U.S. air carriers. Washington D.C.: US Department of Transport, Federal Aviation Administration, Office of Aviation Medicine; 2000.
5. Mohr LC. Hypoxia during air travel in adults with pulmonary disease. Am J Med Sci 2008;335:71-9.
6. Luks AM, Swenson ER. Travel to high altitude with pre-existing lung disease. Eur Respir J 2007;29:770-92.
7. Martin SE, Bradley JM, Buick JB, Bradbury I, Elborn JS. Flight assessment in patients with respiratory disease: Hypoxic challenge testing vs. predictive equations. QJM 2007;100:361-7.
8. Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: A randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 2004;141:169-77.
9. Bartsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation 2007;116:2191-202.
10. British Thoracic Society Standards of Care Committee. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 2002;57:289-304.
11. Ziegler T, Rendelmann S, Albrecht L, Gebauer C, Schoof B. Flugtauglichkeit für Urlaubsreisende. Brandenburgisches Ärzteblatt 2007;3:84-5.
12. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 Expert consensus document on pulmonary hypertension. J Am Coll Cardiol 2009;53:1573-619.
13. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
14. Fischer R, Nowak D, Huber RM. [Fitness to fly of patients with lung disease]. Dtsch Med Wochenschr 2001;126:1115-7.
15. Possick SE, Barry M. Air travel and cardiovascular disease. J Travel Med 2004;11:243-8.
16. Caro JJ, Salas M, Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: Evidence from randomized clinical trials. Clin Ther 2001;23:998-1017.s